输血相关急性肺损伤的研究进展
Research advances in transfusion related acute lung injury
-
摘要: 输血相关急性肺损伤(transfusion-related acute lung injury,TRALI)是在输注血液制剂6 h内出现的,以急性非心源性肺水肿、低氧血症为主要临床表现的综合征。它是输血相关死亡的主要原因,尚无有效的治疗方法。在过去的10年中,体内模型和临床研究提高了我们对TRALI流行病学和发病机制的认识。随着献血策略、血液制备方案等方面的优化,TRALI的发病率已有所下降。本文将从TRALI的临床定义、诊断策略、病理生理机制、治疗方法进行综述,以加深对其的认识和关注,对提高血制品的安全输注具有重要意义。Abstract: Transfusion-related acute lung injury (TRALI) is a syndrome that occurs within 6 hours after blood transfusion.The main clinical symptoms are acute non-cardiogenic pulmonary edema and hypoxemia.It is the main cause of transfusion-related death,and has no specific treatment.In the past decade,in vivo models and clinical researches have improved our understanding to the epidemiology and pathogenesis of TRALI.With the optimization of blood donation strategy and blood preparation plan,its incidence rate has declined.We review the clinical definition,diagnosis strategy,pathophysiological mechanism and treatment methods of TRALI in this article to deepen the understanding and raise the concern of medical colleagues,which is of great significance to improve the safety of blood transfusion.
下载: